CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Top player positioning
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Benefits of rapid tests over laboratory testing
3.4.1.2. Increase in initiatives of government and nonprofit organizations towards health awareness
3.4.1.3. Increase in healthcare expenditure worldwide

3.4.2. Restraint

3.4.2.1. Inadequate reimbursement policies for rapid test diagnostics

3.4.3. Opportunities

3.4.3.1. Growth opportunities in the emerging markets
3.4.3.2. Increase in prevalence of various chronic and infectious diseases across the world

3.4.4. Impact analysis

CHAPTER 4: RAPID TESTS MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Over-the-counter (OTC) rapid test products

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Professional rapid test products

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: RAPID TESTS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Infectious disease

5.2.1. Market size and forecast, by type

5.2.1.1. HPV rapid tests

5.2.1.1.1. Market size and forecast

5.2.1.2. Hepatitis rapid tests

5.2.1.2.1. Market size and forecast

5.2.1.3. Influenza rapid tests

5.2.1.3.1. Market size and forecast

5.2.1.4. Malaria rapid tests

5.2.1.4.1. Market size and forecast

5.2.1.5. HIV rapid tests

5.2.1.5.1. Market size and forecast

5.2.1.6. Other infectious disease rapid tests

5.2.1.6.1. Market size and forecast

5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country

5.3. Cardiology

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Oncology

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Pregnancy & fertility

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Toxicology

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

5.7. Glucose monitoring

5.7.1. Market size and forecast
5.7.2. Market analysis, by country

5.8. Other applications

5.8.1. Market size and forecast
5.8.2. Market analysis, by country

CHAPTER 6: RAPID TESTS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals & clinics

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Diagnostic laboratories

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Home care

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. Others

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

CHAPTER 7: RAPID TESTS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. rapid tests market, by product
7.2.2.1.2. U.S. rapid tests market, by application
7.2.2.1.3. U.S. rapid tests market, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada rapid tests market, by product
7.2.2.2.2. Canada rapid tests market, by application
7.2.2.2.3. Canada rapid tests market, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico rapid tests market, by product
7.2.2.3.2. Mexico rapid tests market, by application
7.2.2.3.3. Mexico rapid tests market, by end user

7.2.3. North America rapid tests market, by product
7.2.4. North America rapid tests market, application
7.2.5. North America rapid tests market, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country

7.3.2.1. Germany

7.3.2.1.1. Germany rapid tests market, by product
7.3.2.1.2. Germany rapid tests market, by application
7.3.2.1.3. Germany rapid tests market, by end user

7.3.2.2. France

7.3.2.2.1. France rapid tests market, by product
7.3.2.2.2. France rapid tests market, by application
7.3.2.2.3. France rapid tests market, by end user

7.3.2.3. UK

7.3.2.3.1. UK rapid tests market, by product
7.3.2.3.2. UK rapid tests market, by application
7.3.2.3.3. UK rapid tests market, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy rapid tests market, by product
7.3.2.4.2. Italy rapid tests market, by application
7.3.2.4.3. Italy rapid tests market, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain rapid tests market, by product
7.3.2.5.2. Spain rapid tests market, by application
7.3.2.5.3. Spain rapid tests market, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe rapid tests market, by product
7.3.2.6.2. Rest of Europe rapid tests market, by application
7.3.2.6.3. Rest of Europe rapid tests market, by end user

7.3.3. Europe rapid tests market, by product
7.3.4. Europe rapid tests market, application
7.3.5. Europe rapid tests market, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan rapid tests market, by product
7.4.2.1.2. Japan rapid tests market, by application
7.4.2.1.3. Japan rapid tests market, by end user

7.4.2.2. China

7.4.2.2.1. China rapid tests market, by product
7.4.2.2.2. China rapid tests market, by application
7.4.2.2.3. China rapid tests market, by end user

7.4.2.3. Australia

7.4.2.3.1. Australia rapid tests market, by product
7.4.2.3.2. Australia rapid tests market, by application
7.4.2.3.3. Australia rapid tests market, by end user

7.4.2.4. India

7.4.2.4.1. India rapid tests market, by product
7.4.2.4.2. India rapid tests market, by application
7.4.2.4.3. India rapid tests market, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea rapid tests market, by product
7.4.2.5.2. South Korea rapid tests market, by application
7.4.2.5.3. South Korea rapid tests market, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific rapid tests market, by product
7.4.2.6.2. Rest of Asia-Pacific rapid tests market, by application
7.4.2.6.3. Rest of Asia-Pacific rapid tests market, by end user

7.4.3. Asia-Pacific rapid tests market, by product
7.4.4. Asia-Pacific rapid tests market, application
7.4.5. Asia-Pacific rapid tests market, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil rapid tests market, by product
7.5.2.1.2. Brazil rapid tests market, by application
7.5.2.1.3. Brazil rapid tests market, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia rapid tests market, by product
7.5.2.2.2. Saudi Arabia rapid tests market, by application
7.5.2.2.3. Saudi Arabia rapid tests market, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Africa rapid tests market, by product
7.5.2.3.2. South Africa rapid tests market, by application
7.5.2.3.3. South Africa rapid tests market, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Rest of LAMEA rapid tests market, by product
7.5.2.4.2. Rest of LAMEA rapid tests market, by application
7.5.2.4.3. Rest of LAMEA rapid tests market, by end user

7.5.3. LAMEA rapid tests market, by product
7.5.4. LAMEA rapid tests market, application
7.5.5. LAMEA rapid tests market, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Akers Biosciences, Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance

8.2. Abbott Laboratories (Alere Inc.)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. Becton, Dickinson and Company

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. Bio-Rad Laboratories, Inc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. Danaher Corporation (Cepheid, Inc.)

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance

8.6. Hologic, Inc.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. Meridian Bioscience, Inc.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance

8.8. OraSure Technologies, Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance

8.9. Quidel Corporation

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. F. Hoffmann-La Roche AG (Roche Diagnostics)

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance